TWST – twist bioscience corporation (US:NASDAQ)

News

Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue [Yahoo! Finance]
Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue
Twist Bioscience (TWST) Valuation Check After TD Cowen Buy Rating And Raised Outlook [Yahoo! Finance]
Twist Bioscience (NASDAQ:TWST) had its price target raised by analysts at TD Cowen from $32.00 to $43.00. They now have a "buy" rating on the stock.
Twist Bioscience (NASDAQ:TWST) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com